AtaiBeckley reports rapid and durable Phase 2a responses to BPL‑003 in treatment‑resistant depression

Solvonis Therapeutics secures second US patent for PTSD compound series

GSK secures China approval for Exdensur to treat nasal polyp condition

Ondine Biomedical ICU study accepted by Journal of Critical Care

Alzinova partners with Amsterdam UMC to advance blood-based Alzheimer's diagnostic

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

CenExel appoints Dr. Sy Pretorius as CEO

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care

Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Aelis Farma secures EUR458k France 2030 grant to advance metabolic disease programme

Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency

NeuroSense's PrimeC composition receives Brazilian patent